OCS
Oculis Holding AG
NASDAQ · Healthcare · Biotechnology · CH
$7.32
+0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 743.48x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.69x
- Price / sales
- 1527.78x
- Price / cash flow
- -5.64x
Enterprise value
- Enterprise value
- $453.9M
- EV / sales
- 1538.21x
- EV / EBITDA
- -4.77x
- EV / EBIT
- -4.29x
- Market cap
- $450.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026